Myovant Sciences (MYOV) Competitor Comparison
We are evaluating the key criteria listed to compare Myovant Sciences (MYOV) against its competitors in the Biotechnology industry.
Market Capitalization
68 / 368Gross Profits
54 / 278Total Revenue
29 / 300EBITDA
242 / 337Free Cashflow
314 / 352Quick Ratio
318 / 357Earnings per Share
205 / 359Dividend yield
0 / 6Total Cash
122 / 358Performance 3 years
28 / 368Performance 5 years
86 / 368Performance 10 years
69 / 368Linearity 3 years
334 / 368Linearity 5 years
128 / 368Linearity 10 years
278 / 368Total Rank
338 / 368Dividend Rank
214 / 368Valuation Rank
220 / 368Piotroski Rank
298 / 368Muliplier Rank
162 / 368Total Cash - MYOV ranking 122 / 358
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.